Radiomics: a potential biomarker for N2 malignancy in clinical stage I lung adenocarcinoma

Documenti analoghi

• CT-based radiomics signature for the stratification of N2 disease risk in clinical stage I lung adenocarcinoma
  di: Yang, Minglei, et al.
  Pubblicazione: (2019)
• Micropapillary or solid pattern predicts recurrence free survival benefit from adjuvant chemotherapy in patients with stage IB lung adenocarcinoma
  di: Ma, Minjie, et al.
  Pubblicazione: (2018)
• A machine learning-based prediction of the micropapillary/solid growth pattern in invasive lung adenocarcinoma with radiomics
  di: He, Bingxi, et al.
  Pubblicazione: (2021)
• Radiomics nomogram for prediction disease-free survival and adjuvant chemotherapy benefits in patients with resected stage I lung adenocarcinoma
  di: Xie, Dong, et al.
  Pubblicazione: (2020)
• Imaging phenotype using radiomics to predict dry pleural dissemination in non-small cell lung cancer
  di: Yang, Minglei, et al.
  Pubblicazione: (2019)